CLINICAL_TRIALS
trial_result
· 2021-06-16
Clinical Trial Update: LCI-GI-APX-NIN-001: Nintedanib in Metastatic Appendiceal Carcinoma [Phase 2]
Summary
Phase 2 trial of nintedanib in metastatic appendiceal carcinoma was terminated; results posted in 2021.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Wake Forest University Health Sciences | Conditions: Appendix Cancer | Phase 2 | Status: TERMINATED | Results posted: 2021-06-16